News

Pfizer’s current PCMM prototype is an autonomous and transportable pod that may be quickly shipped from location to location and readily brought online to create a fully functional

Vidaza is indicated to treat adult patients aged 65 years or older with AML who are not eligible for haematopoietic stem cell transplantation (HSCT). The commission updated Vidaza

The 150-subject, randomized, open-label, multi-center clinical trial will compare the combination regimen to RICE alone. The primary endpoint is the comparison of complete remission rates between the two

Allergan said it had been approached by Pfizer and is in preliminary friendly negotiations with respect to a potential business combination. The company said no agreement has been

Utibron Neohaler (indacaterol/glycopyrrolate), which is expected to be available in the first quarter of next year, can be used for the long-term maintenance treatment of airflow obstruction in

This trial is the first to evaluate the safety and efficacy of OCA in Japanese NASH patients. The primary efficacy analysis was conducted on an intention to treat

The biopharmaceutical firm expects to enroll patients later this year. ProMetic is currently undertaking a phase II clinical trial of PBI-4050 in Canada in patients with metabolic syndrome

The companies will use CEVEC’s CAPGo technology which is optimal for the production of these otherwise difficult to produce recombinant glycoproteins. Financial details of this agreement were not

The NDA is supported by clinical studies exploring the use of 12 weeks of SOF/VEL for patients with genotype 1-6 HCV infection, including patients with compensated cirrhosis and